Sprott’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$531K Hold
8,515
– – 0.02% 177
2026
Q2
$491K Buy
+8,515
New +$489K 0.02% 182

Other funds holding BMY

Sprott's BMY Position: Q3 2026 in Review

Sprott held its Bristol-Myers Squibb (BMY) position steady in Q3 2026 at 8,515 shares worth $531K. The position accounts for 0.02% of the portfolio, ranked #177.

Sprott first reported a position in BMY in Q2 2026 and has held it in 2 quarters since. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Sprott held 8,515 shares of Bristol-Myers Squibb worth $531K as of Q3 2026.
  • Sprott left its Bristol-Myers Squibb share count unchanged in Q3 2026.
  • Bristol-Myers Squibb made up 0.02% of Sprott's portfolio in Q3 2026, its #177 holding.
  • Sprott first reported a position in Bristol-Myers Squibb in Q2 2026 and has held it in 2 quarters since.
  • 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Sprott's 13F filing for Q3 2026, filed 9 Nov 2026.